CanniMed Therapeutics Inc. says it has entered into a decisive agreement with PharmaChoice to supply herbal, oils and oil derivative cannabis products to a some-more than 750 pharmacy locations opposite Canada.
It is a second such understanding announced this week, after Aphria Inc. announced it has entered a five-year agreement to supply pharmacy sequence Shoppers Drug Mart with medical cannabis.
Saskatoon-based CanniMed says PharmaChoice has committed to have it as sole retailer of cannabis products, theme to CanniMed assembly certain product and volume requirements.
Earlier this year, CanniMed sealed a minute of vigilant with member-owned associated PharmaChoice to be a disdainful medical cannabis distributor and to sight a pharmacists and pharmacy technicians.
The association says a understanding with PharmaChoice is still redeeming on Health Canada’s capitulation of medical cannabis product placement by pharmacies.
CanniMed’s supply agreement comes a day after it was told that a Toronto Stock Exchange will defer care of a shareholder rights devise adopted by a association in a bid to urge itself opposite a antagonistic takeover offer by Aurora Cannabis Inc.
The rights devise prevents Vancouver-headquartered Aurora from appropriation any CanniMed shares other than those tendered to a antagonistic bid or from entering into any lock-up agreements other than those it has already sealed and filed, CanniMed has said.
Article source: http://www.cbc.ca/news/business/cannimed-pharma-choice-1.4437352?cmp=rss